Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to
7.4 million doses of vaccine.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
No supplier information available.